EVA FRANCIS: Open Payments
NPI 1316580459 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 56 payments from 13 companies in 2025. Trend: 2023 $689 · 2024 $442 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $438 |
| Axsome Therapeutics, Inc. | 15 | $417 |
| PFIZER INC. | 5 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
| Amgen Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $36 |
| Viatris Specialty LLC | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: Auvelity, VRAYLAR, QULIPTA, UBRELVY, NURTEC ODT, MOUNJARO, ZAVZPRET, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
